138 related articles for article (PubMed ID: 18021020)
1. Antigen-specific tolerance of human alpha1-antitrypsin induced by helper-dependent adenovirus.
Cerullo V; McCormack W; Seiler M; Mane V; Cela R; Clarke C; Rodgers JR; Lee B
Hum Gene Ther; 2007 Dec; 18(12):1215-24. PubMed ID: 18021020
[TBL] [Abstract][Full Text] [Related]
2. Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors.
Pastore L; Morral N; Zhou H; Garcia R; Parks RJ; Kochanek S; Graham FL; Lee B; Beaudet AL
Hum Gene Ther; 1999 Jul; 10(11):1773-81. PubMed ID: 10446917
[TBL] [Abstract][Full Text] [Related]
3. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors.
Morral N; O'Neal W; Zhou H; Langston C; Beaudet A
Hum Gene Ther; 1997 Jul; 8(10):1275-86. PubMed ID: 9215744
[TBL] [Abstract][Full Text] [Related]
4. Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice.
Schowalter DB; Himeda CL; Winther BL; Wilson CB; Kay MA
J Virol; 1999 Jun; 73(6):4755-66. PubMed ID: 10233936
[TBL] [Abstract][Full Text] [Related]
5. Distinct immune responses to transgene products from rAAV1 and rAAV8 vectors.
Lu Y; Song S
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17158-62. PubMed ID: 19805176
[TBL] [Abstract][Full Text] [Related]
6. Toxicity associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector.
O'Neal WK; Zhou H; Morral N; Langston C; Parks RJ; Graham FL; Kochanek S; Beaudet AL
Mol Med; 2000 Mar; 6(3):179-95. PubMed ID: 10965494
[TBL] [Abstract][Full Text] [Related]
7. Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo.
Muruve DA; Cotter MJ; Zaiss AK; White LR; Liu Q; Chan T; Clark SA; Ross PJ; Meulenbroek RA; Maelandsmo GM; Parks RJ
J Virol; 2004 Jun; 78(11):5966-72. PubMed ID: 15140994
[TBL] [Abstract][Full Text] [Related]
8. High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity.
Morral N; Parks RJ; Zhou H; Langston C; Schiedner G; Quinones J; Graham FL; Kochanek S; Beaudet AL
Hum Gene Ther; 1998 Dec; 9(18):2709-16. PubMed ID: 9874269
[TBL] [Abstract][Full Text] [Related]
9. Improved vascular gene transfer with a helper-dependent adenoviral vector.
Wen S; Graf S; Massey PG; Dichek DA
Circulation; 2004 Sep; 110(11):1484-91. PubMed ID: 15326058
[TBL] [Abstract][Full Text] [Related]
10. Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression.
Schowalter DB; Meuse L; Wilson CB; Linsley PS; Kay MA
Gene Ther; 1997 Aug; 4(8):853-60. PubMed ID: 9338015
[TBL] [Abstract][Full Text] [Related]
11. CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses.
Reyes-Sandoval A; Ertl HC
Mol Ther; 2004 Feb; 9(2):249-61. PubMed ID: 14759809
[TBL] [Abstract][Full Text] [Related]
12. Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector.
Oka K; Belalcazar LM; Dieker C; Nour EA; Nuno-Gonzalez P; Paul A; Cormier S; Shin JK; Finegold M; Chan L
Gene Ther; 2007 Feb; 14(3):191-202. PubMed ID: 16957769
[TBL] [Abstract][Full Text] [Related]
13. Toxicological comparison of E2a-deleted and first-generation adenoviral vectors expressing alpha1-antitrypsin after systemic delivery.
O'Neal WK; Zhou H; Morral N; Aguilar-Cordova E; Pestaner J; Langston C; Mull B; Wang Y; Beaudet AL; Lee B
Hum Gene Ther; 1998 Jul; 9(11):1587-98. PubMed ID: 9694157
[TBL] [Abstract][Full Text] [Related]
14. Germline incorporation of a replication-defective adenoviral vector in mice does not alter immune responses to adenoviral vectors.
Camargo FD; Huey-Louie DA; Finn AV; Sassani AB; Cozen AE; Moriwaki H; Schneider DB; Agah R; Dichek DA
Mol Ther; 2000 Nov; 2(5):496-504. PubMed ID: 11082323
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus vector-infected cells can escape adenovirus antigen-specific cytotoxic T-lymphocyte killing in vivo.
Wadsworth SC; Zhou H; Smith AE; Kaplan JM
J Virol; 1997 Jul; 71(7):5189-96. PubMed ID: 9188586
[TBL] [Abstract][Full Text] [Related]
16. Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producing antigen presenting cells.
Zhang HG; Liu D; Heike Y; Yang P; Wang Z; Wang X; Curiel DT; Zhou T; Mountz JD
Nat Biotechnol; 1998 Nov; 16(11):1045-9. PubMed ID: 9831033
[TBL] [Abstract][Full Text] [Related]
17. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.
Van Linthout S; Lusky M; Collen D; De Geest B
Gene Ther; 2002 Nov; 9(22):1520-8. PubMed ID: 12407424
[TBL] [Abstract][Full Text] [Related]
18. An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors.
Kuzmin AI; Galenko O; Eisensmith RC
Mol Ther; 2001 Mar; 3(3):293-301. PubMed ID: 11273770
[TBL] [Abstract][Full Text] [Related]
19. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.
Jooss K; Turka LA; Wilson JM
Gene Ther; 1998 Mar; 5(3):309-19. PubMed ID: 9614550
[TBL] [Abstract][Full Text] [Related]
20. Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions.
Lowenstein PR; Mandel RJ; Xiong WD; Kroeger K; Castro MG
Curr Gene Ther; 2007 Oct; 7(5):347-60. PubMed ID: 17979681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
